Trends Mol Med. 2011 Feb;17(2):78-87. Epub 2010 Nov 4.

Rapamycin for treating Tuberous sclerosis and Autism spectrum disorders.

Source

DZNE, German Center for Neurodegenerative Diseases, Ludwig-Erhard-Allee 2, 53175 Bonn, Germany. Dan.Ehninger@dzne.de

Abstract

Tuberous sclerosis (TSC) is a genetic disorder caused by heterozygous mutations in the TSC1 or TSC2 genes and is associated with autism spectrum disorders (ASD) in 20-60% of cases. In addition, altered TSC/mTOR signaling is emerging as a feature common to a subset of ASD. Recent findings, in animal models, show that restoration of the underlying molecular defect can improve neurological dysfunction in several of these models, even if treatment is initiated in adult animals, suggesting that pathophysiological processes in the mature brain contribute significantly to the overall neurological phenotype in these models. These findings suggest that windows for therapeutic intervention in ASD could be wider than thought previously.

Published by Elsevier Ltd.

PMID:: 21115397; [PubMed - indexed for MEDLINE]
PMCID:: PMC3075964

Free PMC Article

Images from this publication.See all images (1) Free text

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

Review

MeSH Terms

Substances

Grant Support

R01 MH084315-10/MH/NIMH NIH HHS/United States

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Molecular Biology Databases

SIROLIMUS - HSDB

Supplemental Content

Save items

Related citations in PubMed

Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex. [Hum Mol Genet. 2011]
Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex.
Zeng LH, Rensing NR, Zhang B, Gutmann DH, Gambello MJ, Wong M. Hum Mol Genet. 2011 Feb 1; 20(3):445-54. Epub 2010 Nov 9.
Efficacy of combined inhibition of mTOR and ERK/MAPK pathways in treating a tuberous sclerosis complex cell model. [J Genet Genomics. 2009]
Efficacy of combined inhibition of mTOR and ERK/MAPK pathways in treating a tuberous sclerosis complex cell model.
Mi R, Ma J, Zhang D, Li L, Zhang H. J Genet Genomics. 2009 Jun; 36(6):355-61.
Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function. [J Neurosci. 2008]
Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function.
Meikle L, Pollizzi K, Egnor A, Kramvis I, Lane H, Sahin M, Kwiatkowski DJ. J Neurosci. 2008 May 21; 28(21):5422-32.
Review Non-canonical functions of the tuberous sclerosis complex-Rheb signalling axis. [EMBO Mol Med. 2011]
Review Non-canonical functions of the tuberous sclerosis complex-Rheb signalling axis.
Neuman NA, Henske EP. EMBO Mol Med. 2011 Apr; 3(4):189-200. Epub 2011 Mar 16.
Review Everolimus: an mTOR inhibitor for the treatment of tuberous sclerosis. [Expert Rev Anticancer Ther. 2011]
Review Everolimus: an mTOR inhibitor for the treatment of tuberous sclerosis.
Franz DN. Expert Rev Anticancer Ther. 2011 Aug; 11(8):1181-92.

See reviews... See all...

Cited by 1 PubMed Central article

Plasticity and mTOR: Towards Restoration of Impaired Synaptic Plasticity in mTOR-Related Neurogenetic Disorders. [Neural Plast. 2012]
Plasticity and mTOR: Towards Restoration of Impaired Synaptic Plasticity in mTOR-Related Neurogenetic Disorders.
Gipson TT, Johnston MV. Neural Plast. 2012; 2012:486402. Epub 2012 Apr 30.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance
PubChem chemical substance records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Rapamycin for treating Tuberous sclerosis and Autism spectrum disorders.
Rapamycin for treating Tuberous sclerosis and Autism spectrum disorders.
Trends Mol Med. 2011 Feb ;17(2):78-87. Epub 2010 Nov 4 .

PubMed
Potency ranking of valproic acid analogues as to inhibition of cardiac different...
Potency ranking of valproic acid analogues as to inhibition of cardiac differentiation of embryonic stem cells in comparison to their in vivo embryotoxicity.
Reprod Toxicol. 2011 May ;31(4):375-82. Epub 2010 Nov 27 .

PubMed
Ribosomal protein L11 mutation in zebrafish leads to haematopoietic and metaboli...
Ribosomal protein L11 mutation in zebrafish leads to haematopoietic and metabolic defects.
Br J Haematol. 2011 Jan ;152(2):217-28. doi: 10.1111/j.1365-2141.2010.08396.x. Epub 2010 Nov 29 .

PubMed
Adenosine triphosphatases of rat pancreatic islets: comparison with those of rat...
Adenosine triphosphatases of rat pancreatic islets: comparison with those of rat kidney.
J Clin Invest. 1978 Sep ;62(3):692-701.

PubMed
Predation of human pathogens by the predatory bacteria Micavibrio aeruginosavoru...
Predation of human pathogens by the predatory bacteria Micavibrio aeruginosavorus and Bdellovibrio bacteriovorus.
J Appl Microbiol. 2011 Feb ;110(2):431-44. doi: 10.1111/j.1365-2672.2010.04900.x. Epub 2010 Nov 29 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: